Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pusey

Showing results (321-330 of 380) with videos related to

Pageof 38
Sort By:
Journal of the American Society of Nephrology : JASN|April 5, 2014
Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GNStephen P McAdoo, John Reynolds, Gurjeet Bhangal, et al.
Journal of Autoimmunity|April 6, 2015
Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'John Reynolds, Gloria A Preston, Barrak M Pressler, et al.
Kidney International|September 24, 2021
Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitisKavita Gulati, Helena Edwards, Maria Prendecki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2004
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitisFrederick W K Tam, Jan-Stephan Sanders, Abraham George, et al.
BMC Nephrology|September 8, 2019
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trialAikaterini Nikolopoulou, Marie Condon, Tabitha Turner-Stokes, et al.
Nature Genetics|April 30, 2008
Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibilityJacques Behmoaras, Gurjeet Bhangal, Jennifer Smith, et al.
Scientific Reports|January 2, 2020
Modification of an aggressive model of Alport Syndrome reveals early differences in disease pathogenesis due to genetic backgroundSara Falcone, Laura Wisby, Thomas Nicol, et al.
Kidney International|February 21, 2013
Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritisRuth J Pepper, Sally Hamour, Konstantia-Maria Chavele, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 24, 2015
Outcome and treatment of elderly patients with ANCA-associated vasculitisMaria Weiner, Su Mein Goh, Aladdin J Mohammad, et al.
Genetics|April 29, 2017
Identification of Ceruloplasmin as a Gene that Affects Susceptibility to Glomerulonephritis Through Macrophage FunctionTai-Di Chen, Maxime Rotival, Ling-Yin Chiu, et al.
Pageof 38

Showing results (321-330 of 380) with videos related to

Sort By:
Pageof 38
Journal of the American Society of Nephrology : JASN|April 5, 2014
Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GNStephen P McAdoo, John Reynolds, Gurjeet Bhangal, et al.
Journal of Autoimmunity|April 6, 2015
Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'John Reynolds, Gloria A Preston, Barrak M Pressler, et al.
Kidney International|September 24, 2021
Combination treatment with rituximab, low-dose cyclophosphamide and plasma exchange for severe antineutrophil cytoplasmic antibody-associated vasculitisKavita Gulati, Helena Edwards, Maria Prendecki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2004
Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitisFrederick W K Tam, Jan-Stephan Sanders, Abraham George, et al.
BMC Nephrology|September 8, 2019
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trialAikaterini Nikolopoulou, Marie Condon, Tabitha Turner-Stokes, et al.
Nature Genetics|April 30, 2008
Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibilityJacques Behmoaras, Gurjeet Bhangal, Jennifer Smith, et al.
Scientific Reports|January 2, 2020
Modification of an aggressive model of Alport Syndrome reveals early differences in disease pathogenesis due to genetic backgroundSara Falcone, Laura Wisby, Thomas Nicol, et al.
Kidney International|February 21, 2013
Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritisRuth J Pepper, Sally Hamour, Konstantia-Maria Chavele, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 24, 2015
Outcome and treatment of elderly patients with ANCA-associated vasculitisMaria Weiner, Su Mein Goh, Aladdin J Mohammad, et al.
Genetics|April 29, 2017
Identification of Ceruloplasmin as a Gene that Affects Susceptibility to Glomerulonephritis Through Macrophage FunctionTai-Di Chen, Maxime Rotival, Ling-Yin Chiu, et al.
Pageof 38